Business
Alembic Pharmaceuticals Received 8 USFDA Approvals in Q3FY24 6cc41
2nd January 2023, India: Alembic Pharmaceuticals Limited (Alembic) announced that it has received US Food & Drug istration (USFDA) approvals on eight of its Abbreviated New Drug Application (ANDA) in Q3FY24. The Company has received […]